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1. INTRODUCTION 
Bovine vasopressin precursor is composed of 
three domains, namely vasopressin, neurophysin II 
(MSEL-neurophysin) and a glycopeptide, which 
are cut out by intraneuronal processing [ 11. In most 
placental mammals investigated, on the one hand 
two neurohypophysial hormones, arginine vaso- 
pressin and oxytocin have been identified [2,3], on 
the other hand two neurophysins, termed MSEL- 
and VLDV-neurophysins according to the nature of 
amino acids in positions 2,3,6 and 7, have been 
characterized ]2,4]. In man, the two hormones have 
been isolated [5] using the neurophysin complex 
procedure [6] and the two neurophysins have been 
purified by polyacrylamide gel electrophoresis [7,8]. 
As a response to nicotine stimulation, arginine vaso- 
pressin and MSEL-neurophysin are selectively 
secreted in blood [7,8] and this co-secretion agrees 
with the presence of a common precursor similar to 
the one identified in ox. Furthermore a human 
neurohypophysial glycopeptide, homologous to the 
bovine glycopeptide [9], has recently been identi- 
fied [IO]. We report here the complete amino acid 
sequence of human MSEL-neurophysin, homo- 
logous to the neurophysin component of the bovine 
vasopressin precursor. 
pressor activity, the fourth 0.34 U/mg of oxytocic 
activity and 0.36 U/mg of pressor activity. 
Extraction, carried out on l-g samples with 0.1 M 
HCl (50 ml/g), was followed by molecular sieving 
on Sephadex G-75 in 0.1 M formic acid and the 
crude neurophysin fraction was subjected to 
ion-exchange chromatography on DEAE-Sepha- 
dex A-50 using a stepwise ionic-strength gradient 
made with pyridine acetate (pH 5.9) under the 
conditions described for bovine neurophysins [ 111. 
MSEL-neurophysin was recovered in the second 
peak of the fraction eluted over 0.15-0.30 M and 
VLDV-neurophysin in the third peak. A C-terminal 
truncated MSEL-neurophysin was found in the 
peak eluted over 0.4-0.6 M. In a typical experi- 
ment, 1 g acetonic posterior pituitary powder gave 
33.5 mg crude neurophysins from which 2.7 mg 
(- 300 nmol) of intact MSEL-neurophysin were 
isolated. 
2. MATERIALS AND METHODS 
Pituitary glands, placed in acetone at the time of 
post-mortem examination, were collected in various 
hospitals of Paris through France-Hypophyse. The 
posterior lobes were separated in the laboratory and 
pulverized. Four batches of 148, 112, 220 and 230 
glands gave 10.5 g material. The third batch titrated 
at 0.25 U/mg of oxytocic activity and 0.30 U/mg of 
MSEL-neurophysin, intact or truncated, was 
oxidized by performic acid and split either by tryp- 
sin or by staphylococcal proteinase and the resul- 
ting peptides were separated by paper chromato- 
electrophoresis under the conditions in [ 1 I]. After 
elution with 0.25% acetic acid, peptides were hy- 
drolyzed (6 M HCI in vacua, 48 h, 105°C) and 
subjected to amino acid analysis in a Spinco model 
120 B amino acid analyzer [12]. Amino acid se- 
quences of the peptides were determined by a 
manual Edman degradation [ 131 either directly or 
after cleavage by subtilisin, chymotrypsin or staphy- 
lococcal proteinase, isolation of subfragments 
and determination of their sequences. The two 
overlapping sets of tryptic and staphylococcal pro- 
teinase peptides allowed us to determine the align- 
ment (fig.1). On the other hand MSEL-neurophy- 
sin, reduced by dithiothreitol and alkylated with 
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iodoacetamide [14] was subjected to automated 
Edman degradation [ 151 in a Socosi model P 110 
sequencer under the conditions in [ 111. Phenylthio- 
hydantoins were identified by thin-layer chroma- 
tography [ 161 and by high-pressure liquid chroma- 
tography [ 171. 
3. RESULTS AND DISCUSSION 
The complete amino acid sequence of MSEL- 
neurophysin was deduced from the various results 
(fig.1). In the C-terminal truncated form, the last 4 
residues were missing. 
W I _- Tl 
In fig.2 are shown MSEL-neurophysins charac- 
terized in ox [ 181, sheep [ 181, pig [ 19.201, horse [2 I], 
whale [22], rat [23] and man. In human 
MSEL-neurophysin, there is an apparent deletion 
of 2 residues and the number of residues is 93 in- 
stead of 95; the C-terminal tripeptide Arg-Arg- 
Ala found in pig, horse and whale is, however, pres- 
ent, so that residues usually in positions 91 and 92 
are supposed deleted. The number of amino acid 
variations when compared with bovine 
MSEL-neurophysin [18] is 9 (7 substitutions and 2 
deletions). There are 4 substitutions in the ‘constant’ 
region (lo-74), namely in position 29 (Ala/Gly), 60 
T 
15 f ., 207' 5 4 i 1w 
Ala-Met-Ser-Asp-Leu-Glu-Lep-Arg-Gln-Cys-Leu-Pro-Cys-Gly-Pro-Gly-Gly-Lys~Gly-Argv 
t- Seq 
t------___Tl__-______JC----_----_T2________ ___)G T3_j 
st2 st3 
> 
~______________--__---_-T~__--_____- ------ -------- 
+ T4(st+s)l-----+<T4(s'+d2>+-T4(St+S)3- +- -T4(st+s)4- ++T4(st+s)5MT4(st+s)6+ 
T4 st4 T5 
5 45 1 50 55 5 60 
Ala-Leu-Arg-Cys-Gln-Glu-Glu-Asn-Tyr-Leu-Pro-Ser-Pro-Cys-Gln-Ser-G~y-Gln-Lys-Ala 
_______J~___________________------T~------------------~f-- 
-T4(st+s)7++--T5sl- --+C----- -T5s2-----_-_-+~---T5s3----~ 
T5' st5 
65 J 70 75 1 80 
Cys-Gly-Ser-Gly-Gly-Arg-Cys-Ala-Ala-Phe-Gly-Val-Cys-Cys-Asn-Asp-Glu-Ser-Cys-Ual 
__- T5'-_---__-_-__-)~---___-----_------__T6______________ 
l ---T6s1---+_)t--T6s2-+~---_6s3-- +c----- 
St6 T6 st7 
--------------+-)t__ -T7------_+-T8-j 
-T6s4------_+-T6s5-j +stScl++ - -stSc2- -+ 
Fig.1. Amino acid sequence of human MSEL-neurophysin. Tryptic (T) and staphylococcal proteinase (St) peptides are 
shown by arrows. Subfragments obtained by subtilisin (s), chymotrypsin (c), staphylococcal proteinase (St), are indicated 
as T5s1, St8c1, etc. and those obtained by an enzyme mixture as T4(st + s)l, etc. Seq: sequence determined by automated 
Edman degradation. 
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12 5 10 15 20 
Ala-Met-Ser-Asp-Leu-Glu-Leu-Arq-Gln-Cys-Leu-Pro-Cys-Gly-PrO-Gly-Gly-LyS-Gly-Arq 
- Thr - Met 










65 70 72 75 80 
Cys-Gly-Ser-Gly-Gly-Arq~ys-Ala-Ala-Ala-Gly-Ile-Cys-Cys-Asn-Asp-Glu-Ser-Cys-Val 
Ser 
Phe - Val c 
81 85 Ile 90 91 92 94 95 
Thr-Glu-Pro-Glu-Cys-Arq-Glu-Gly-Val-Gly-Phe-Pro-Arq-Arq-Val 
Ile 
Ala-Ser - Leu Ala 
Ala - Leu Ala 
Ala-Ser Ala 
Ala Phe-Phe[. 3 - Leu-Thr 
Phe-His[ Ala 
Fig.2. Comparison of bovine [ 181, ovine [ 181, porcine [ 19,201, equine 12 11, whale 1221, rat [23] and human MSEL-neuro- 
physins. Solid lines indicate residues identical with those of bovine protein. [ ] assumed deletion. 
(Ala/Pro), 70 (Phe/Ala) and 72 (Val/Ile). In the 
‘hypervariable’ sequence (89-95), there are 5 
variations. Human MSEL-neurophysin appears 
more related to bovine MSEL-neurophysin that is 
the rat MSEL-neurophysin (12 variations), but of 
7 mammals investigated, only human and rat 
MSEL-neurophysins have 93 residues. 
A second human neurophysin, which can easily 
be classified in the VLDV-family by its N-terminal 
sequence, has also been purified. This type of neuro- 
physin is co-secreted with oxytocin [7,24] and can 
be regarded as a fragment of the oxytocin macro- 
molecular precursor [25]. 
A so-called human neurophysin II has recently 
been purified and its N-terminal (24 residues) and 
C-terminal (6 residues) sequences have been deter- 
mined [26]. The N-terminal sequence resembles 
that of MSEL-neurophysin but threonine instead of 
lysine is found in position 18 and the C-terminal 
sequence is Ser-Phe-Leu-Arg-Arg-Val instead 
of Gly-Phe-His-Arg-Arg-Ala. The discrepancy 
for the C-terminal sequence cannot still be 
explained. 
Arginine vasopressin was identified in man 25 
years ago by qualitative amino acid composition IS]. 
The peptide fraction recovered from molecular 
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Amino acid composition of human neurohypophysial hormones 

































1.00 1 .oo (1) 
0.11 0.10 - 
1 .oo 1.08 (1) 
1.05 1 .oo (1) 
1.01 1.06 (1) 
0.08 
1.04 0.94 (1) 
1.08 1.07 (1) 
0.73 (1) 
1.02 1.03 (1) 
1.10 (2) 
1 .oo 1 .oo (1) 
0.13 0.17 
1.15 1.21 m 
1.02 1.14 (1) 
1.17 1.29 (1) 
0.16 
0.52 (1) 
1.08 1.14 (1) 
a Half-cystines are determined as cysteic acid on a separate performic acid-oxidized sample 
A partial destruction of cysteic acid is observed when hydrolysis is carried out with paper-eluted peptide. Tyrosine, 
destroyed in the oxidized sample, is partially protected when hydrolysis is performed under reducing conditions 
(addition of mercaptoethanol) 
Values are in molar ratios, using aspartic acid as reference 
sieving of the extract on Sephadex G-75, has been 
passed on Biogel P4 in order to separate the neuro- 
hypophysial hormones [27] and the pressor hormone 
has been purified by paper chromatoelectro- 
phoresis under the conditions in 1281. The amino 
acid composition corresponds to that of arginine 
vasopressin (table 1). 
pressin and MSEL-neurophysin as in bovine pre- 
cursor [l]. Because of the shortening of human 
MSEL-neurophysin, the interval between MSEL- 
neurophysin and the glycopeptide may not be 
limited to the single arginine found in the bovine 
precursor. 
The human glycopeptide homologous to the gly- 
copeptide component of bovine vasopressin pre- 
cursor has already been identified [lo]. This peptide 
has 39 residues, 6 of which are substituted in man; it 
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